United Kingdom · Question · Written question
UIN 93949
Puberty Suppressing Hormones: Children
Introduced
24 November 2025
Last action
3 December 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
3 December 2025
Summary
To ask the Secretary of State for Health and Social Care, how many children under the age of 16 were administered puberty blockers, including through (a) clinical trials and (b) private routes in each of the last five years; and what adverse effects were
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
24 November 2025
Written question
To ask the Secretary of State for Health and Social Care, how many children under the age of 16 were administered puberty blockers, including through (a) clinical trials and (b) private routes in each of the last five years; and what adverse effects were
Source: Commons
3 December 2025
Answer
Gonadotropin-releasing hormone agonists or ‘puberty blockers’ are used to treat several medical conditions in children and young people. These can include precocious puberty, some forms of cancer, and endometriosis. They have been used outside of their li...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-11-24/93949
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1856346
- uk · wq-1856346 · source updated 3 December 2025